MITF and melanoma: In BRAF inhibitor-treated melanoma cells, MITF was differentially expressed to promote proliferation (high MITF to induce MLANA, PMEL, TYRP genes) or invasion (low MITF to induce high AXL, WNT5A, TEAD, JUN expression) [34,80,81,82].